Small molecules, diagnostics, traditional
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
150
NCT05154201
Treatment of Patients With Advanced Solid Tumors With Oral Agent ORIN1001 and in Combination With Standard of Care.
Phase: Phase 1/2
Role: Collaborator
Start: Jul 1, 2020
Completion: Jan 30, 2025
Loading map...